Connect with us

Cannabis News

EU regulators say Charlotte’s Web hemp CBD safety “cannot be established”

Published

1 month ago

on

The growing tension between international scientific findings and US health policy has raised questions about whether Medicare beneficiaries are being exposed to cannabinoid products whose safety profiles have not been fully established.

In March 2026, the European Food Safety Authority (EFSA) carried out a formal scientific evaluation of a shipment of Charlotte’s Web hemp product, concluding that the safety of a carbon dioxide extract derived from Cannabis sativa L. “cannot be established”. The agency identified several gaps in the available data, including significant portions of the product remaining uncharacterized, a lack of reliable toxicological studies on the actual material, a lack of human clinical data, and an unknown allergenicity and long-term safety profile.

At the same time, the Centers for Medicare and Medicaid Services (CMS) launched the Substance Access Beneficiary Engagement Incentive (BEI) program. The initiative allows participating healthcare providers to discuss and supply certain hemp and marijuana-derived cannabinoid products to Medicare beneficiaries under the authority of the Center for Innovation, and does not require approval from the US Food and Drug Administration. That distinction is at issue in a pending federal case: Smart Approaches to Marijuana (SAM), et al. Robert F. Kennedy Jr. et al., Case 1:26-cv-01081 (U.S. District Court for the District of Columbia).

Under the FDA’s standard framework, products intended for therapeutic use typically undergo controlled clinical trials, dose standardization, safety and toxicology evaluation, and manufacturing and stability validation. The BEI program operates outside of this structure. Some observers point out that this could introduce products into federally funded care settings before those benchmarks are met, while proponents of the program characterize it as a legitimate model of innovation.

Medicare beneficiaries represent a medically complex population, with many patients managing multiple medications, chronic conditions, and increased susceptibility to drug interactions. Cannabinoid compounds, including THC, interact with metabolic pathways such as CYP450 enzymes, which process many common medications. The safety profile of these products in this population has not been fully characterized through controlled studies.

Following the launch of the program, several companies publicly announced their positioning within the emerging healthcare supply chain. Charlotte’s Web highlighted alignment with CMS drivers and Cornbread Hemp announced institutional distribution through a national group buying organization, reflecting broader commercialization activity in the category.

SAM v. In Kennedy, the court is evaluating whether CMS overstepped its statutory authority by introducing avenues for the supply of cannabinoids without formal regulations, public notice and comment, or FDA validation standards. A resolution will determine whether the program is scaled back, modified, or stopped pending further review as implemented.

The EFSA’s conclusion does not ban the marketing of CBD products, but indicates that the scientific evidence necessary to fully establish their safety remains incomplete. The political debate reflects a broader question in health care regulation: how to balance the pace of innovation for therapeutic products with the standards of evidence typically required in federally funded systems of care.

Source: MMJ International Holdings

Related Topics:
Continue Reading

Cannabis News

Columbia hemp business Burning Acre to close and move to North Carolina over new Tennessee rules

Published

10 hours ago

on

June 14, 2026

By











Burning Acre, a Columbia, Tennessee-based hemp company, says it will close its retail store and move operations to North Carolina ahead of new state regulations that take effect July 1, according to WSMV.

The business says its last day to open in Columbia will be June 30, the same day the Tennessee Department of Agriculture licenses for hemp-derived cannabinoids expire. As of July 1, businesses that continue to operate in the state will be required to be licensed under a new regulatory framework led by the Tennessee Alcoholic Beverage Commission.

Burning Acre says the changes have forced it to abandon plans for a new sandwich shop and bakery and close its Tennessee retail operations and relocate to Murphy, North Carolina. “I won’t sugarcoat it, it’s a very hard video for me and a message I should never have written,” the business wrote.

The business puts the annual cost of manufacturing, distribution and running the retail store at about $750. Under the new rules, he says, those costs would rise by tens of thousands of dollars, citing new licensing fees, a required $25,000 annual bond and increased testing fees.

The law, which took effect in July, changes the regulation of hemp-derived cannabinoid businesses from the Department of Agriculture to the ABC. The Department of Agriculture stopped issuing licenses at the end of 2025, and the licenses issued by the TDA will remain valid until June 30, 2026.

“Columbia, we absolutely love being a part of this community,” said Burning Acre. “We are truly heartbroken to have to say goodbye to this location.”

Read more at WSMV4










Continue Reading

Cannabis News

North Carolina Lawmakers Advance Bill To Set A Minimum Age Limit For Hemp And Kratom Products

Published

10 hours ago

on

June 14, 2026

By

“Many other details about cannabis have been debated and will continue to be debated.”

By Christine Zhu, NC Newsline

Lawmakers in North Carolina are considering banning people under 21 from buying or possessing certain hemp-derived consumables, including combustible hemp flower, hemp cigarettes, gummies and drinks, or items that include the drug kratom.

The House Agriculture and Environment Committee approved a rewrite of Senate Bill 59 on Wednesday. This is the latest attempt by state legislators after years of proposals to regulate the sale of hemp products that didn’t work out in the end.

This measure would prohibit companies from selling such products to under-21s. If the seller has “reasonable grounds” to believe that the buyer is under the age of 21, the seller must verify the buyer’s ID.

Rep. Jimmy Dixon (R-Duplin), who introduced the bill, said he was motivated to bring public attention to issues surrounding cannabis. He said there was a 14-year-old boy in his neighborhood who had an emergency after buying a hemp-derived product.

“There are a lot of other details about cannabis that have been debated and will continue to be debated, but ladies and gentlemen, to make sure we have the good sense to be agents of these kinds of issues, that’s the lowest hanging fruit,” he said.

Violators would face a Class 2 felony, as well as a fine of $500 for a first offense, $1,000 for a second offense and $1,500 for subsequent offenses.

asked Rep. Pricey Harrison (D-Guilford). of the bill language resulted in potential changes to hemp-derived products. It is common for manufacturers of synthetic recreational drugs to make changes to the chemical composition of their products to avoid legal bans or restrictions.

“I assume the definition as written is broad enough to capture any future manipulation of molecules,” he said. Dixon nodded.

Legislators also voted in favor correction To add kratom products to the under-21 ban.

Rep. Jeffrey McNeely (R-Iredell), who proposed the amendment, said it was necessary to add those elements to the bill.

“I’ve been working on this for quite some time, trying to get these bills passed,” McNeely said. “We definitely have a problem. So I’m hoping we can keep posting this and we’ll get something done before we get out of the short session here.”

Both the amendment and the legislation passed unanimously without debate.

The bill moves next to the House Rules Committee. Other amendments will be heard when they appear on the House floor, which could be as soon as next week.

This story was first published by NC Newsline.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

GreenTech Amsterdam 2026 in 2026 photos

Published

1 day ago

on

June 13, 2026

By











Well, it’s not 2026 photos, but with around 600 photos, we definitely did our best. For the past two days, the Netherlands has been the place to be for the global greenhouse industry. From Flower Trials for the horticulture sector, company visits to growers and technical suppliers, as well as dinners, get-togethers, drinks, knowledge sessions and much more. And of course with GreenTech Amsterdam.

The event brought together professionals from around the world to connect, network, share knowledge and do business.

Next week, we’ll be sharing more information on market developments, trends, what’s on display, news, business news, innovations and whatever else you can think of, but for now we’ll stick to photo reporting.

Click here for the photo report.

© Arlette Sijmonsma | MMJDaily.com










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media